Found 8 matching trials
Biosimilar Study Comparing PK, PD, Safety and Immunogencity of BP11 With US Licensed Xolair and EU Approved Xolair
PHASE1A single dose, double blind comparative trial to assess the pharmacokinetic...
A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases
PHASE1This study aims to evaluate the safety, tolerability, pharmacokinetics (PK)...
Location
Hallym University Sacred Heart Hospital
A Multiple Ascending Dose, Phase 1b Study of YH35324 in Atopic Healthy Subjects or Subjects With Allergic Diseases
PHASE1This study aims to evaluate the safety, tolerability, pharmacokinetic (PK) ...
Location
Soonchunhyang University Bucheon Hospital
Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria
PHASE3The purpose of the study is to compare the efficacy, safety, tolerability, ...
Location
True Blue Clinical Research
Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria
PHASE3The purpose of the study is to compare the efficacy, pharmacokinetics, phar...
Protection From Food Induced Anaphylaxis by Reducing the Serum Level of Specific IgE (Protana).
PHASE4Anaphylaxis elicited by accidental intake of the offending food constitutes...
Location
Odense Research Center for Anaphylaxis, Allergy Center
Omalizumab Before Onset of Exacerbations
PHASE2OBOE is a prospective, pilot, parallel group RCT with the overall aim of ex...
Location
Children's National Hospital
To Compare Efficacy and Safety of CT-P39 and EU-approved Xolair in Patients With Chronic Spontaneous Urticaria
PHASE3A Double-blind, Randomized, Active-controlled, Parallel Group, Phase 3 Stud...
Location
Klinika Ambroziak ESTEDERM